Home Healthcare

Healthcare

Healthcare company and market news.

Medicare Part B recipients who have received premium notifications for January 2022 may have noticed a price increase on their premiums. The average monthly Part B premium is expected to run around $170.10 next year. Part B insurance, which pays for durable medical equipment and outpatient care, cost enrollees...
According to Ladders, Covid-19 vaccine mandates doubled last month in job listings. Data from Indeed also show that vaccine requirements are up for those looking for work. CEO and Founder of Ladders Marc Cenedella said, “To see something doubling month-over-month indicates real change in the economy and companies’ behavior.” Cenedella added...
This week, the Food and Drug Administration has approved and authorized Moderna and J&J booster shots against the COVID-19 virus. The federal authority also said that people could mix and match vaccines and get a different booster shot than the one received during initial dosing.  The Centers for Disease Control...
According to a survey by the Employee Benefit Research Institute (EBRI), one in three U.S. employees said they saw an increase in their healthcare-related costs this past year. Because of the higher expenses, many workers put the charges on their credit cards (48 percent) or reduced their retirement savings...
Scientific studies show that Moderna may be more effective against the COVID 19 delta variant than the Pfizer/BioNTech mRNA vaccine. MedRxiv posted two reports on Sunday highlighting the studies’ findings. The studies showed that the odds of a breakthrough COVID-19 diagnosis rise with time. Anyone who received a second dose...
Freelancers and contract and gig workers often miss out on finding affordable prescription medications because they don’t have a group health insurance policy to fall back on. But, things might change for the better due to a new partnership between GoodRx and DoorDash. The deal between the two companies...
According to the Centers for Disease Control (CDC), nearly half of all Americans have received at least one COVID-19 vaccine dose, while 40 percent have had a complete vaccine. In all, 165.7 million of the 332 million eligible Americans have begun a vaccination program against the virus. Almost 133...
Moderna announced on Wednesday that early trials show promising evidence that a booster shot of its vaccine offers increased protection and immunity against COVID-19 variants circulating around the world, including those first discovered in South Africa and Brazil.  The company is also studying another...
The U.S. government is planning to allocate $1.7 billion to track newer, more contagious strains of the COVID-19 variants making their way through the world. The funding is earmarked to improve monitoring, early detection, and mitigation measures of the more dangerous strains. Currently, newer...
Pfizer just announced that its COVID-19 vaccine is 100 percent effective in preventing the virus in adolescents aged 12 through 15. The pharmaceutical company’s CEO, Albert Bourla, says they will be submitting the new data on the vaccine to the FDA “as soon as possible.” If all...